Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u prethodnih 30 dana:7
  • preuzimanja u prethodnih 30 dana:4
članak: 4 od 22  
Back povratak na rezultate
Serbian Journal of Anesthesia and Intensive Therapy
2011, vol. 33, br. 3-4, str. 225-229
jezik rada: engleski
vrsta rada: pregledni članak

Prokalcitonin kao vodič antibiotske terapije kod kritično obolelih pacijenata
Univerzitet u Segedinu Odeljenje anestezije i intenzivne terapije, Segedin, Mađarska

e-adresa: z_molnar@hotmail.com

Sažetak

Antibitska terapija je mač sa dve oštrice: sa jedne strane, u teškoj sepsi i septičnom šoku, svaki sat odlaganja započinjanja antibiotske terapije značajno redukuje šanse bolesnika za preživljavanje, dok, sa druge strane, primena antibiotika onda kada nisu neophodni, dovodi do prekomernog rasta multi-rezistentnih patogena. Zbog toga je razlikovanje sistemskog inflamatornog odgovora od infekcije od osnovnog značaja, iako to nije uvek lako. Zbog svoje senzitivnosti i specifičnosti, izgleda da je serumski prokalcitonin najbolji marker sepse danas, koji takođe pomaže kao vodič za antibiotsku terapiju. Cilj ovog revijalnog pregleda je da sumira poruke najvažnijih članaka koji su nedavno objavljeni iz ove oblasti.

Ključne reči

Reference

Albrich, W.C., Monnet, D.L., Harbarth, S. (2004) Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerging infectious diseases, 10(3): 514-7
American College of Chest Physicins (1992) Definitions for sepsis and organ failure and guidelines for the use innovative therapies in sepsis. Crit Care Med, 20(6), str. 864-74
Assicot, M., Gendrel, D., Carsin, H., Raymond, J., Guilbaud, J., Bohuon, C. (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet, 341(8844): 515-8
Bone, R.C., Fisher, C.J., Clemmer, T.P., i dr. (1987) A controlled clinical trial of high dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med, 317, str. 654-658
Bouadma, L., Luyt, C., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., Bernard, M., Pasquet, B., i dr. (2010) Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet, 375(9713): 463-74
Castelli, G.P., Pognani, C., Meisner, M., Stuani, A., Bellomi, D., Sgarbi, L. (2004) Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care, 8(4), str. 234-42
Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M.M., Huber, P.R., Tamm, M., Muller, B. (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet, 363(9409): 600-7
Daniels, J.M.A., Schoorl, M., Snijders, D., Knol, D.L., Lutter, R., Jansen, H.M., Boersma, W.G. (2010) Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest, 138(5): 1108-15
de Werra, I., Jaccard, C., Corradin, S.B., Chiolero, R., Yersin, B., Gallati, H., Assicot, M., Bohuon, C., Baumgartner, J.D., Glauser, M.P., Heumann, D. (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med, 25(4): 607-13
Dellinger, P., Carlet, J.M., Levy, M.M., i dr. (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Intensive Care Med, 34: 17-60
Jensen, J.U., Hein, L., Lundgren, B., Bestle, M.H., Mohr, T.T., Andersen, M.H., Thornberg, K.J., Løken, J., Steensen, M., Fox, Z., Tousi, H., Søe-Jensen, P., Lauritsen, A.Ø., i dr. (2011) Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Critical care medicine, 39(9): 2048-58
Jensen, J.U., Heslet, L., Jensen, T.H., Espersen, K., Steffensen, P., Tvede, M. (2006) Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Critical care medicine, 34(10): 2596-602
Kumar, A., Roberts, D., Wood, K.E., Light, B., Parrillo, J.E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., Gurka, D., Kumar, A., Cheang, M. (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical care medicine, 34(6): 1589-96
Meisner, M., Tschaikowsky, K., Schnabel, S., Schmidt, J., Katalinic, A., Schüttler, J. (1997) Procalcitonin--influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. European journal of clinical chemistry and clinical biochemistry, 35(8): 597-601
Mimoz, O., Benoist, J.F., Edouard, A.R., Assicot, M., Bohuon, C., Samii, K. (1998) Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive care medicine, 24(2): 185-8
Molnar, Z., Szakmany, T., Koszegi, T., Tekeres, M. (2000) Microalbuminuria and serum procalcitonin levels following oesophagectomy. Eur J Anaesthesiol, 17(7): 464-5
Müller, F., Christ-Crain, M., Bregenzer, T., Krause, M., Zimmerli, W., Mueller, B., Schuetz, P. (2010) Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest, 138(1): 121-9
Nobre, V., Harbarth, S., Graf, J., Rohner, P., Pugin, J. (2008) Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. American journal of respiratory and critical care medicine, 177(5): 498-505
Simon, L., Gauvin, F., Amre, D.K., Saint-Louis, P., Lacroix, J. (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clinical infectious diseases, 39(2): 206-17
Suprin, E., Camus, C., Gacouin, A., le Tulzo, Y., Lavoue, S., Feuillu, A., Thomas, R. (2000) Procalcitonin: A valuable indicator of infection in a medical ICU?. Intensive Care Med, 26(9): 1232-8
Szakmany, T., Molnar, Z. (2003) Procalcitonin levels do not predict mortality following major abdominal surgery. Canadian journal of anaesthesia, 50(10): 1082-3
Thompson, D., Milford-Ward, A., Whicher, J.T. (1992) The value of acute phase protein measurements in clinical practice. Ann Clin Biochem, 29(Pt 2): 123-31